$309 Million is the total value of Endurant Capital Management LP's 86 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 45.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $14,170,000 | -14.3% | 231,229 | +4.4% | 4.59% | -17.0% |
| HLS | Buy | HEALTHSOUTH CORP | $13,765,000 | +8.5% | 365,790 | +0.4% | 4.46% | +5.1% |
| AET | Buy | AETNA INC NEW | $10,697,000 | +15.0% | 95,215 | +10.7% | 3.46% | +11.4% |
| HRC | Buy | HILL ROM HLDGS INC | $9,930,000 | +241.4% | 197,424 | +226.2% | 3.22% | +230.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $9,907,000 | +94.6% | 526,698 | +90.8% | 3.21% | +88.5% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $8,973,000 | +113.2% | 106,514 | +115.6% | 2.91% | +106.6% |
| BIIB | Buy | BIOGEN INC | $8,521,000 | -11.8% | 32,732 | +3.8% | 2.76% | -14.6% |
| STJ | Buy | ST JUDE MED INC | $8,024,000 | +2.4% | 145,882 | +15.0% | 2.60% | -0.8% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $7,573,000 | +26.7% | 53,486 | +26.9% | 2.45% | +22.7% |
| AGN | Buy | ALLERGAN PLC | $7,371,000 | -0.1% | 27,500 | +16.5% | 2.39% | -3.2% |
| SYK | Buy | STRYKER CORP | $7,334,000 | +42.3% | 68,360 | +23.3% | 2.38% | +37.8% |
| EVHC | New | ENVISION HEALTHCARE HLDGS IN | $7,311,000 | – | 358,400 | +100.0% | 2.37% | – |
| SHPG | Buy | SHIRE PLCsponsored adr | $6,834,000 | +125.1% | 39,753 | +168.4% | 2.21% | +118.1% |
| MCK | Buy | MCKESSON CORP | $6,816,000 | +9.5% | 43,347 | +37.3% | 2.21% | +6.1% |
| HCA | Buy | HCA HOLDINGS INC | $6,414,000 | +43.2% | 82,180 | +24.1% | 2.08% | +38.7% |
| GILD | Buy | GILEAD SCIENCES INC | $6,229,000 | +45.2% | 67,810 | +59.9% | 2.02% | +40.6% |
| AMAG | Buy | AMAG PHARMACEUTICALS INC | $6,205,000 | +84.8% | 265,180 | +138.5% | 2.01% | +79.0% |
| ANTM | Buy | ANTHEM INC | $6,063,000 | +695.7% | 43,624 | +698.0% | 1.96% | +670.2% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $5,227,000 | +61.4% | 41,907 | +54.6% | 1.69% | +56.3% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $4,733,000 | +28.4% | 40,412 | +35.6% | 1.53% | +24.3% |
| CNC | Buy | CENTENE CORP DEL | $4,669,000 | -4.3% | 75,838 | +2.3% | 1.51% | -7.3% |
| FLDM | Buy | FLUIDIGM CORP DEL | $4,384,000 | +0.6% | 543,290 | +34.7% | 1.42% | -2.6% |
| VWR | New | VWR CORP | $4,205,000 | – | 155,389 | +100.0% | 1.36% | – |
| PFE | Buy | PFIZER INC | $4,141,000 | -0.8% | 139,700 | +8.0% | 1.34% | -3.9% |
| New | FLUIDIGM CORP DELnote 2.750% 2/0 | $3,957,000 | – | 7,261,000 | +100.0% | 1.28% | – | |
| A | Buy | AGILENT TECHNOLOGIES INC | $3,622,000 | +24.3% | 90,885 | +30.4% | 1.17% | +20.4% |
| DVA | Buy | DAVITA HEALTHCARE PARTNERS I | $2,993,000 | +352.8% | 40,789 | +329.9% | 0.97% | +338.9% |
| KMPH | Buy | KEMPHARM INC | $2,459,000 | +18.1% | 169,586 | +61.7% | 0.80% | +14.3% |
| PMC | New | PHARMERICA CORP | $2,200,000 | – | 99,490 | +100.0% | 0.71% | – |
| BCR | New | BARD C R INC | $1,925,000 | – | 9,500 | +100.0% | 0.62% | – |
| KTWO | New | K2M GROUP HLDGS INC | $1,888,000 | – | 127,300 | +100.0% | 0.61% | – |
| WMGI | Buy | WRIGHT MED GROUP N V | $1,886,000 | -0.8% | 113,628 | +44.5% | 0.61% | -3.9% |
| ILMN | Buy | ILLUMINA INC | $1,832,000 | +228.9% | 11,300 | +289.7% | 0.59% | +218.8% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $1,789,000 | +59.3% | 117,568 | +54.1% | 0.58% | +54.3% |
| AMPH | Buy | AMPHASTAR PHARMACEUTICALS IN | $1,682,000 | -7.6% | 140,150 | +9.5% | 0.54% | -10.5% |
| HZNP | Buy | HORIZON PHARMA PLC | $1,638,000 | +35.1% | 98,840 | +76.7% | 0.53% | +31.1% |
| GMED | Buy | GLOBUS MED INCcl a | $1,560,000 | +25.6% | 65,700 | +47.2% | 0.50% | +21.7% |
| CNMD | New | CONMED CORP | $1,178,000 | – | 28,090 | +100.0% | 0.38% | – |
| PEN | New | PENUMBRA INC | $1,136,000 | – | 24,700 | +100.0% | 0.37% | – |
| MDVN | Buy | MEDIVATION INC | $1,062,000 | +91.0% | 23,100 | +100.9% | 0.34% | +84.9% |
| AMGN | New | AMGEN INC | $840,000 | – | 5,600 | +100.0% | 0.27% | – |
| CRL | Buy | CHARLES RIV LABS INTL INC | $827,000 | +19.9% | 10,888 | +26.8% | 0.27% | +16.0% |
| INCY | Buy | INCYTE CORP | $565,000 | -8.6% | 7,800 | +36.8% | 0.18% | -11.6% |
| AERI | New | AERIE PHARMACEUTICALS INC | $525,000 | – | 43,200 | +100.0% | 0.17% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $518,000 | – | 13,100 | +100.0% | 0.17% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $516,000 | – | 17,500 | +100.0% | 0.17% | – |
| PRGO | New | PERRIGO CO PLC | $461,000 | – | 3,600 | +100.0% | 0.15% | – |
| NXTM | New | NXSTAGE MEDICAL INC | $396,000 | – | 26,400 | +100.0% | 0.13% | – |
| DPLO | New | DIPLOMAT PHARMACY INC | $378,000 | – | 13,800 | +100.0% | 0.12% | – |
| WOOF | New | VCA INC | $363,000 | – | 6,300 | +100.0% | 0.12% | – |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $355,000 | -55.2% | 13,500 | +73.1% | 0.12% | -56.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.